In a sweeping new proposal focused on Medicare Advantage and Medicare Part D, the CMS is considering a policy to cut off pharmacy profits through rebates and give Medicare Part D plans more power to negotiate protected class drug prices.
In a sweeping new proposal focused on Medicare Advantage and Medicare Part D, the CMS is considering a policy to cut off pharmacy profits through rebates and give Medicare Part D plans more power to negotiate protected class drug prices.